Effect of Prenatal Glucocorticoids on Cerebral Vasculature of the Developing Brain
Open Access
- 1 August 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 41 (8), 1766-1773
- https://doi.org/10.1161/strokeaha.110.588400
Abstract
Background and Purpose— Prenatal glucocorticoids prevent germinal matrix hemorrhage in premature infants. The underlying mechanism, however, is elusive. Germinal matrix is enriched with angiogenic vessels exhibiting paucity of pericytes and glial fibrillary acidic protein-positive astrocyte end feet. Therefore, we asked whether glucocorticoid treatment would suppress angiogenesis and enhance periendothelial coverage by pericytes and glial fibrillary acidic protein-positive end feet in the germinal matrix microvasculature. Methods— We treated pregnant rabbits with intramuscular betamethasone and delivered pups prematurely by cesarean section at E29 (term=32 days). Endothelial turnover, vascular density, pericyte coverage, glial fibrillary acidic protein-positive end feet, cell death, and growth factors orchestrating angiogenesis, including vascular endothelial growth factor, angiopoietins, transforming growth factor-β, and platelet-derived growth factor-B, were compared between betamethasone-treated and untreated pups. Similar comparisons were done between autopsy materials from premature infants exposed and unexposed to prenatal glucocorticoids. Results— Antenatal glucocorticoid treatment reduced endothelial proliferation, vascular density, and vascular endothelial growth factor expression in the germinal matrix of both rabbits and humans. The pericyte coverage was greater in glucocorticoid-treated rabbit pups and human infants than in controls, but not the glial fibrillary acidic protein-positive end feet coverage. Transforming growth factor-β, but not angiopoietins and platelet-derived growth factor-B, were elevated in glucocorticoid-treated rabbit pups compared with controls. Betamethasone treatment induced apoptosis, neuronal degeneration, and gliosis in rabbit pups. However, there was no evidence of increased cell death in glucocorticoid-exposed human infants. Conclusions— Prenatal glucocorticoid suppresses vascular endothelial growth factor and elevates transforming growth factor-β levels, which results in angiogenic inhibition, trimming of neovasculature, and enhanced pericyte coverage. These changes contribute to stabilizing the germinal matrix vasculature, thereby reducing its propensity to hemorrhage. Prenatal glucocorticoid exposure does not induce neural cell death in humans, unlike rabbits.This publication has 33 references indexed in Scilit:
- Intraventricular Hemorrhage in Premature Infants: Mechanism of DiseasePediatric Research, 2010
- Characterization of Acute Brain Injuries and Neurobehavioral Profiles in a Rabbit Model of Germinal Matrix HemorrhageStroke, 2008
- Effects of maternal antenatal glucocorticoid treatment on apoptosis in the ovine fetal cerebral cortexJournal of Neuroscience Research, 2008
- Dexamethasone coordinately regulates angiopoietin-1 and VEGF: A mechanism of glucocorticoid-induced stabilization of blood–brain barrierBiochemical and Biophysical Research Communications, 2008
- Glucocorticoids Suppress Tumor Angiogenesis and In vivo Growth of Prostate Cancer CellsClinical Cancer Research, 2006
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- A Single Course of Prenatal Betamethasone in the Rat Alters Postnatal Brain Cell Proliferation but not ApoptosisJournal Of Physiology-London, 2003
- Statistics, not memories: what was the standard of care for administering antenatal steroids to women in preterm labor between 1985 and 2000?Obstetrics & Gynecology, 2003
- Efficacy of a single dose of antenatal steroid in surfactant-treated babies under 31 weeks' gestationThe Journal of Maternal-Fetal & Neonatal Medicine, 2002
- Antenatal betamethasone-dose-effects on fetal rat lung morphology and surfactantjpme, 1994